PCN310 REAL WORLD SURVIVAL OUTCOMES WITH MODIFIED DOSE SCHEDULE OF BORTEZOMIB, MELPHALAN AND PREDNISONE IN PREVIOUSLY UNTREATED TRANSPLANT INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA: A POPULATION BASED OBSERVATIONAL STUDY
May 1, 2019, 00:00
10.1016/j.jval.2019.04.428
https://www.valueinhealthjournal.com/article/S1098-3015(19)30620-5/fulltext
Title :
PCN310 REAL WORLD SURVIVAL OUTCOMES WITH MODIFIED DOSE SCHEDULE OF BORTEZOMIB, MELPHALAN AND PREDNISONE IN PREVIOUSLY UNTREATED TRANSPLANT INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA: A POPULATION BASED OBSERVATIONAL STUDY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30620-5&doi=10.1016/j.jval.2019.04.428
First page :
Section Title :
Open access? :
No
Section Order :
10071